nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC1—epilepsy syndrome	0.405	0.5	CbGaD
Dihydroxyaluminium—VDAC2—epilepsy syndrome	0.405	0.5	CbGaD
Dihydroxyaluminium—VDAC1—hindbrain—epilepsy syndrome	0.00427	0.0797	CbGeAlD
Dihydroxyaluminium—VDAC2—forebrain—epilepsy syndrome	0.00298	0.0557	CbGeAlD
Dihydroxyaluminium—VDAC2—telencephalon—epilepsy syndrome	0.00274	0.0512	CbGeAlD
Dihydroxyaluminium—VDAC3—forebrain—epilepsy syndrome	0.00248	0.0464	CbGeAlD
Dihydroxyaluminium—VDAC1—brainstem—epilepsy syndrome	0.00245	0.0457	CbGeAlD
Dihydroxyaluminium—VDAC1—forebrain—epilepsy syndrome	0.00236	0.0441	CbGeAlD
Dihydroxyaluminium—VDAC3—telencephalon—epilepsy syndrome	0.00228	0.0426	CbGeAlD
Dihydroxyaluminium—VDAC3—Niclosamide—Clonazepam—epilepsy syndrome	0.00223	1	CbGdCrCtD
Dihydroxyaluminium—VDAC1—telencephalon—epilepsy syndrome	0.00217	0.0406	CbGeAlD
Dihydroxyaluminium—VDAC2—spinal cord—epilepsy syndrome	0.00192	0.0359	CbGeAlD
Dihydroxyaluminium—VDAC3—medulla oblongata—epilepsy syndrome	0.00179	0.0335	CbGeAlD
Dihydroxyaluminium—VDAC2—head—epilepsy syndrome	0.00171	0.0319	CbGeAlD
Dihydroxyaluminium—VDAC1—medulla oblongata—epilepsy syndrome	0.00171	0.0319	CbGeAlD
Dihydroxyaluminium—VDAC3—midbrain—epilepsy syndrome	0.00164	0.0306	CbGeAlD
Dihydroxyaluminium—VDAC2—nervous system—epilepsy syndrome	0.00162	0.0302	CbGeAlD
Dihydroxyaluminium—VDAC3—spinal cord—epilepsy syndrome	0.0016	0.0299	CbGeAlD
Dihydroxyaluminium—VDAC1—midbrain—epilepsy syndrome	0.00156	0.0291	CbGeAlD
Dihydroxyaluminium—VDAC2—central nervous system—epilepsy syndrome	0.00156	0.0291	CbGeAlD
Dihydroxyaluminium—VDAC2—cerebellum—epilepsy syndrome	0.00152	0.0284	CbGeAlD
Dihydroxyaluminium—VDAC1—spinal cord—epilepsy syndrome	0.00152	0.0284	CbGeAlD
Dihydroxyaluminium—VDAC3—head—epilepsy syndrome	0.00142	0.0266	CbGeAlD
Dihydroxyaluminium—VDAC1—head—epilepsy syndrome	0.00135	0.0253	CbGeAlD
Dihydroxyaluminium—VDAC3—nervous system—epilepsy syndrome	0.00135	0.0252	CbGeAlD
Dihydroxyaluminium—VDAC3—central nervous system—epilepsy syndrome	0.0013	0.0242	CbGeAlD
Dihydroxyaluminium—VDAC1—nervous system—epilepsy syndrome	0.00128	0.0239	CbGeAlD
Dihydroxyaluminium—VDAC3—cerebellum—epilepsy syndrome	0.00127	0.0237	CbGeAlD
Dihydroxyaluminium—VDAC2—brain—epilepsy syndrome	0.00124	0.0231	CbGeAlD
Dihydroxyaluminium—VDAC1—central nervous system—epilepsy syndrome	0.00123	0.0231	CbGeAlD
Dihydroxyaluminium—VDAC1—cerebellum—epilepsy syndrome	0.00121	0.0225	CbGeAlD
Dihydroxyaluminium—VDAC3—brain—epilepsy syndrome	0.00103	0.0192	CbGeAlD
Dihydroxyaluminium—VDAC1—brain—epilepsy syndrome	0.00098	0.0183	CbGeAlD
Dihydroxyaluminium—Dehydration—Gabapentin—epilepsy syndrome	0.000198	0.00148	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000198	0.00148	CcSEcCtD
Dihydroxyaluminium—Infection—Fosphenytoin—epilepsy syndrome	0.000196	0.00147	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Pregabalin—epilepsy syndrome	0.000195	0.00146	CcSEcCtD
Dihydroxyaluminium—Back pain—Carbamazepine—epilepsy syndrome	0.000195	0.00146	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000194	0.00146	CcSEcCtD
Dihydroxyaluminium—Hypotension—Midazolam—epilepsy syndrome	0.000194	0.00145	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000193	0.00145	CcSEcCtD
Dihydroxyaluminium—Oedema—Vigabatrin—epilepsy syndrome	0.000193	0.00144	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Rufinamide—epilepsy syndrome	0.000192	0.00144	CcSEcCtD
Dihydroxyaluminium—Nausea—Trimethadione—epilepsy syndrome	0.000192	0.00144	CcSEcCtD
Dihydroxyaluminium—Infection—Vigabatrin—epilepsy syndrome	0.000191	0.00143	CcSEcCtD
Dihydroxyaluminium—Convulsion—Zonisamide—epilepsy syndrome	0.000191	0.00143	CcSEcCtD
Dihydroxyaluminium—Vertigo—Clonazepam—epilepsy syndrome	0.000191	0.00143	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Carbamazepine—epilepsy syndrome	0.00019	0.00142	CcSEcCtD
Dihydroxyaluminium—Vertigo—Phenytoin—epilepsy syndrome	0.000189	0.00142	CcSEcCtD
Dihydroxyaluminium—Dizziness—Phenobarbital—epilepsy syndrome	0.000189	0.00142	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Topiramate—epilepsy syndrome	0.000189	0.00142	CcSEcCtD
Dihydroxyaluminium—Infection—Diazepam—epilepsy syndrome	0.000188	0.00141	CcSEcCtD
Dihydroxyaluminium—Vertigo—Oxcarbazepine—epilepsy syndrome	0.000188	0.00141	CcSEcCtD
Dihydroxyaluminium—Back pain—Lamotrigine—epilepsy syndrome	0.000188	0.00141	CcSEcCtD
Dihydroxyaluminium—Thirst—Topiramate—epilepsy syndrome	0.000188	0.00141	CcSEcCtD
Dihydroxyaluminium—Dizziness—Rufinamide—epilepsy syndrome	0.000186	0.00139	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Diazepam—epilepsy syndrome	0.000185	0.00139	CcSEcCtD
Dihydroxyaluminium—Hypotension—Fosphenytoin—epilepsy syndrome	0.000185	0.00138	CcSEcCtD
Dihydroxyaluminium—Oedema—Felbamate—epilepsy syndrome	0.000184	0.00138	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Lamotrigine—epilepsy syndrome	0.000183	0.00137	CcSEcCtD
Dihydroxyaluminium—Convulsion—Phenytoin—epilepsy syndrome	0.000183	0.00137	CcSEcCtD
Dihydroxyaluminium—Infection—Felbamate—epilepsy syndrome	0.000182	0.00137	CcSEcCtD
Dihydroxyaluminium—Vomiting—Phenobarbital—epilepsy syndrome	0.000182	0.00136	CcSEcCtD
Dihydroxyaluminium—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000182	0.00136	CcSEcCtD
Dihydroxyaluminium—Urticaria—Acetazolamide—epilepsy syndrome	0.000181	0.00136	CcSEcCtD
Dihydroxyaluminium—Pain—Propofol—epilepsy syndrome	0.000181	0.00136	CcSEcCtD
Dihydroxyaluminium—Vertigo—Carbamazepine—epilepsy syndrome	0.000181	0.00135	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Lacosamide—epilepsy syndrome	0.000181	0.00135	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Acetazolamide—epilepsy syndrome	0.00018	0.00135	CcSEcCtD
Dihydroxyaluminium—Oedema—Zonisamide—epilepsy syndrome	0.00018	0.00135	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Topiramate—epilepsy syndrome	0.00018	0.00135	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Felbamate—epilepsy syndrome	0.000179	0.00134	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Gabapentin—epilepsy syndrome	0.000179	0.00134	CcSEcCtD
Dihydroxyaluminium—Vomiting—Rufinamide—epilepsy syndrome	0.000179	0.00134	CcSEcCtD
Dihydroxyaluminium—Infection—Zonisamide—epilepsy syndrome	0.000179	0.00134	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Valproic Acid—epilepsy syndrome	0.000178	0.00133	CcSEcCtD
Dihydroxyaluminium—Pain—Midazolam—epilepsy syndrome	0.000177	0.00133	CcSEcCtD
Dihydroxyaluminium—Hypotension—Diazepam—epilepsy syndrome	0.000177	0.00133	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Zonisamide—epilepsy syndrome	0.000175	0.00131	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Clobazam—epilepsy syndrome	0.000175	0.00131	CcSEcCtD
Dihydroxyaluminium—Pain—Levetiracetam—epilepsy syndrome	0.000175	0.00131	CcSEcCtD
Dihydroxyaluminium—Vertigo—Lamotrigine—epilepsy syndrome	0.000175	0.00131	CcSEcCtD
Dihydroxyaluminium—Dizziness—Lacosamide—epilepsy syndrome	0.000174	0.00131	CcSEcCtD
Dihydroxyaluminium—Convulsion—Carbamazepine—epilepsy syndrome	0.000174	0.00131	CcSEcCtD
Dihydroxyaluminium—Oedema—Clonazepam—epilepsy syndrome	0.000173	0.0013	CcSEcCtD
Dihydroxyaluminium—Infection—Clonazepam—epilepsy syndrome	0.000172	0.00129	CcSEcCtD
Dihydroxyaluminium—Hypotension—Felbamate—epilepsy syndrome	0.000172	0.00129	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Valproic Acid—epilepsy syndrome	0.000171	0.00128	CcSEcCtD
Dihydroxyaluminium—Infection—Phenytoin—epilepsy syndrome	0.000171	0.00128	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Topiramate—epilepsy syndrome	0.00017	0.00128	CcSEcCtD
Dihydroxyaluminium—Nausea—Phenobarbital—epilepsy syndrome	0.00017	0.00127	CcSEcCtD
Dihydroxyaluminium—Infection—Oxcarbazepine—epilepsy syndrome	0.00017	0.00127	CcSEcCtD
Dihydroxyaluminium—Dizziness—Clobazam—epilepsy syndrome	0.000169	0.00127	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Clonazepam—epilepsy syndrome	0.000169	0.00127	CcSEcCtD
Dihydroxyaluminium—Convulsion—Lamotrigine—epilepsy syndrome	0.000168	0.00126	CcSEcCtD
Dihydroxyaluminium—Urticaria—Propofol—epilepsy syndrome	0.000168	0.00126	CcSEcCtD
Dihydroxyaluminium—Hypotension—Zonisamide—epilepsy syndrome	0.000168	0.00126	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Phenytoin—epilepsy syndrome	0.000168	0.00126	CcSEcCtD
Dihydroxyaluminium—Vomiting—Lacosamide—epilepsy syndrome	0.000168	0.00126	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Propofol—epilepsy syndrome	0.000168	0.00126	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000167	0.00125	CcSEcCtD
Dihydroxyaluminium—Nausea—Rufinamide—epilepsy syndrome	0.000167	0.00125	CcSEcCtD
Dihydroxyaluminium—Dehydration—Topiramate—epilepsy syndrome	0.000166	0.00125	CcSEcCtD
Dihydroxyaluminium—Pain—Vigabatrin—epilepsy syndrome	0.000165	0.00123	CcSEcCtD
Dihydroxyaluminium—Urticaria—Midazolam—epilepsy syndrome	0.000165	0.00123	CcSEcCtD
Dihydroxyaluminium—Oedema—Carbamazepine—epilepsy syndrome	0.000164	0.00123	CcSEcCtD
Dihydroxyaluminium—Infection—Carbamazepine—epilepsy syndrome	0.000163	0.00122	CcSEcCtD
Dihydroxyaluminium—Vomiting—Clobazam—epilepsy syndrome	0.000163	0.00122	CcSEcCtD
Dihydroxyaluminium—Pain—Diazepam—epilepsy syndrome	0.000162	0.00122	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000162	0.00121	CcSEcCtD
Dihydroxyaluminium—Hypotension—Clonazepam—epilepsy syndrome	0.000162	0.00121	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Pregabalin—epilepsy syndrome	0.000161	0.00121	CcSEcCtD
Dihydroxyaluminium—Hypotension—Phenytoin—epilepsy syndrome	0.000161	0.0012	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Carbamazepine—epilepsy syndrome	0.00016	0.0012	CcSEcCtD
Dihydroxyaluminium—Hypotension—Oxcarbazepine—epilepsy syndrome	0.00016	0.0012	CcSEcCtD
Dihydroxyaluminium—Chills—Valproic Acid—epilepsy syndrome	0.000159	0.00119	CcSEcCtD
Dihydroxyaluminium—Oedema—Lamotrigine—epilepsy syndrome	0.000159	0.00119	CcSEcCtD
Dihydroxyaluminium—Infection—Lamotrigine—epilepsy syndrome	0.000158	0.00118	CcSEcCtD
Dihydroxyaluminium—Urticaria—Fosphenytoin—epilepsy syndrome	0.000157	0.00118	CcSEcCtD
Dihydroxyaluminium—Pain—Felbamate—epilepsy syndrome	0.000157	0.00118	CcSEcCtD
Dihydroxyaluminium—Nausea—Lacosamide—epilepsy syndrome	0.000157	0.00117	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000156	0.00117	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000156	0.00117	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Lamotrigine—epilepsy syndrome	0.000155	0.00116	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Pregabalin—epilepsy syndrome	0.000155	0.00116	CcSEcCtD
Dihydroxyaluminium—Hypotension—Carbamazepine—epilepsy syndrome	0.000153	0.00115	CcSEcCtD
Dihydroxyaluminium—Urticaria—Vigabatrin—epilepsy syndrome	0.000153	0.00115	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Midazolam—epilepsy syndrome	0.000153	0.00115	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000152	0.00114	CcSEcCtD
Dihydroxyaluminium—Nausea—Clobazam—epilepsy syndrome	0.000152	0.00114	CcSEcCtD
Dihydroxyaluminium—Dizziness—Acetazolamide—epilepsy syndrome	0.000151	0.00113	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000151	0.00113	CcSEcCtD
Dihydroxyaluminium—Urticaria—Diazepam—epilepsy syndrome	0.000151	0.00113	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Topiramate—epilepsy syndrome	0.000151	0.00113	CcSEcCtD
Dihydroxyaluminium—Back pain—Valproic Acid—epilepsy syndrome	0.000149	0.00112	CcSEcCtD
Dihydroxyaluminium—Pain—Clonazepam—epilepsy syndrome	0.000148	0.00111	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Gabapentin—epilepsy syndrome	0.000148	0.00111	CcSEcCtD
Dihydroxyaluminium—Pain—Oxcarbazepine—epilepsy syndrome	0.000146	0.0011	CcSEcCtD
Dihydroxyaluminium—Urticaria—Felbamate—epilepsy syndrome	0.000146	0.00109	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Valproic Acid—epilepsy syndrome	0.000146	0.00109	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Felbamate—epilepsy syndrome	0.000145	0.00109	CcSEcCtD
Dihydroxyaluminium—Vomiting—Acetazolamide—epilepsy syndrome	0.000145	0.00109	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Propofol—epilepsy syndrome	0.000145	0.00109	CcSEcCtD
Dihydroxyaluminium—Chills—Pregabalin—epilepsy syndrome	0.000144	0.00108	CcSEcCtD
Dihydroxyaluminium—Urticaria—Zonisamide—epilepsy syndrome	0.000143	0.00107	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Zonisamide—epilepsy syndrome	0.000142	0.00106	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000142	0.00106	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Gabapentin—epilepsy syndrome	0.000142	0.00106	CcSEcCtD
Dihydroxyaluminium—Pain—Carbamazepine—epilepsy syndrome	0.00014	0.00105	CcSEcCtD
Dihydroxyaluminium—Dizziness—Propofol—epilepsy syndrome	0.00014	0.00105	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00014	0.00105	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Diazepam—epilepsy syndrome	0.00014	0.00105	CcSEcCtD
Dihydroxyaluminium—Vertigo—Valproic Acid—epilepsy syndrome	0.000139	0.00104	CcSEcCtD
Dihydroxyaluminium—Urticaria—Clonazepam—epilepsy syndrome	0.000138	0.00103	CcSEcCtD
Dihydroxyaluminium—Dizziness—Midazolam—epilepsy syndrome	0.000137	0.00103	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Clonazepam—epilepsy syndrome	0.000137	0.00103	CcSEcCtD
Dihydroxyaluminium—Urticaria—Phenytoin—epilepsy syndrome	0.000137	0.00102	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Phenytoin—epilepsy syndrome	0.000136	0.00102	CcSEcCtD
Dihydroxyaluminium—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000136	0.00102	CcSEcCtD
Dihydroxyaluminium—Pain—Lamotrigine—epilepsy syndrome	0.000136	0.00102	CcSEcCtD
Dihydroxyaluminium—Nausea—Acetazolamide—epilepsy syndrome	0.000136	0.00102	CcSEcCtD
Dihydroxyaluminium—Dizziness—Levetiracetam—epilepsy syndrome	0.000135	0.00101	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000135	0.00101	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000135	0.00101	CcSEcCtD
Dihydroxyaluminium—Back pain—Pregabalin—epilepsy syndrome	0.000135	0.00101	CcSEcCtD
Dihydroxyaluminium—Vomiting—Propofol—epilepsy syndrome	0.000135	0.00101	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000132	0.000992	CcSEcCtD
Dihydroxyaluminium—Chills—Gabapentin—epilepsy syndrome	0.000132	0.000989	CcSEcCtD
Dihydroxyaluminium—Vomiting—Midazolam—epilepsy syndrome	0.000132	0.000988	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000132	0.000988	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Pregabalin—epilepsy syndrome	0.000132	0.000987	CcSEcCtD
Dihydroxyaluminium—Dizziness—Fosphenytoin—epilepsy syndrome	0.000131	0.000979	CcSEcCtD
Dihydroxyaluminium—Urticaria—Carbamazepine—epilepsy syndrome	0.00013	0.000978	CcSEcCtD
Dihydroxyaluminium—Vomiting—Levetiracetam—epilepsy syndrome	0.00013	0.000976	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Carbamazepine—epilepsy syndrome	0.00013	0.000973	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Diazepam—epilepsy syndrome	0.00013	0.000973	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000128	0.000956	CcSEcCtD
Dihydroxyaluminium—Dizziness—Vigabatrin—epilepsy syndrome	0.000127	0.000955	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000127	0.00095	CcSEcCtD
Dihydroxyaluminium—Oedema—Valproic Acid—epilepsy syndrome	0.000126	0.000945	CcSEcCtD
Dihydroxyaluminium—Urticaria—Lamotrigine—epilepsy syndrome	0.000126	0.000945	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000126	0.000945	CcSEcCtD
Dihydroxyaluminium—Nausea—Propofol—epilepsy syndrome	0.000126	0.000944	CcSEcCtD
Dihydroxyaluminium—Vomiting—Fosphenytoin—epilepsy syndrome	0.000126	0.000942	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Felbamate—epilepsy syndrome	0.000126	0.000941	CcSEcCtD
Dihydroxyaluminium—Vertigo—Pregabalin—epilepsy syndrome	0.000126	0.000941	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000125	0.00094	CcSEcCtD
Dihydroxyaluminium—Dizziness—Diazepam—epilepsy syndrome	0.000125	0.00094	CcSEcCtD
Dihydroxyaluminium—Infection—Valproic Acid—epilepsy syndrome	0.000125	0.000939	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Topiramate—epilepsy syndrome	0.000124	0.00093	CcSEcCtD
Dihydroxyaluminium—Back pain—Gabapentin—epilepsy syndrome	0.000124	0.000929	CcSEcCtD
Dihydroxyaluminium—Nausea—Midazolam—epilepsy syndrome	0.000123	0.000923	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Valproic Acid—epilepsy syndrome	0.000123	0.000922	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Zonisamide—epilepsy syndrome	0.000123	0.000921	CcSEcCtD
Dihydroxyaluminium—Vomiting—Vigabatrin—epilepsy syndrome	0.000122	0.000918	CcSEcCtD
Dihydroxyaluminium—Nausea—Levetiracetam—epilepsy syndrome	0.000122	0.000912	CcSEcCtD
Dihydroxyaluminium—Dizziness—Felbamate—epilepsy syndrome	0.000121	0.00091	CcSEcCtD
Dihydroxyaluminium—Convulsion—Pregabalin—epilepsy syndrome	0.000121	0.000907	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000121	0.000907	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Gabapentin—epilepsy syndrome	0.000121	0.000905	CcSEcCtD
Dihydroxyaluminium—Vomiting—Diazepam—epilepsy syndrome	0.000121	0.000904	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Topiramate—epilepsy syndrome	0.000119	0.000894	CcSEcCtD
Dihydroxyaluminium—Dizziness—Zonisamide—epilepsy syndrome	0.000119	0.000891	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Clonazepam—epilepsy syndrome	0.000118	0.000888	CcSEcCtD
Dihydroxyaluminium—Hypotension—Valproic Acid—epilepsy syndrome	0.000118	0.000883	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Phenytoin—epilepsy syndrome	0.000118	0.000882	CcSEcCtD
Dihydroxyaluminium—Nausea—Fosphenytoin—epilepsy syndrome	0.000117	0.00088	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000117	0.000877	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000117	0.000876	CcSEcCtD
Dihydroxyaluminium—Vomiting—Felbamate—epilepsy syndrome	0.000117	0.000875	CcSEcCtD
Dihydroxyaluminium—Vertigo—Gabapentin—epilepsy syndrome	0.000115	0.000862	CcSEcCtD
Dihydroxyaluminium—Dizziness—Clonazepam—epilepsy syndrome	0.000115	0.000858	CcSEcCtD
Dihydroxyaluminium—Nausea—Vigabatrin—epilepsy syndrome	0.000114	0.000858	CcSEcCtD
Dihydroxyaluminium—Vomiting—Zonisamide—epilepsy syndrome	0.000114	0.000856	CcSEcCtD
Dihydroxyaluminium—Oedema—Pregabalin—epilepsy syndrome	0.000114	0.000854	CcSEcCtD
Dihydroxyaluminium—Dizziness—Phenytoin—epilepsy syndrome	0.000114	0.000852	CcSEcCtD
Dihydroxyaluminium—Infection—Pregabalin—epilepsy syndrome	0.000113	0.000849	CcSEcCtD
Dihydroxyaluminium—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000113	0.000848	CcSEcCtD
Dihydroxyaluminium—Nausea—Diazepam—epilepsy syndrome	0.000113	0.000844	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000112	0.000842	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Pregabalin—epilepsy syndrome	0.000111	0.000834	CcSEcCtD
Dihydroxyaluminium—Chills—Topiramate—epilepsy syndrome	0.000111	0.000832	CcSEcCtD
Dihydroxyaluminium—Convulsion—Gabapentin—epilepsy syndrome	0.000111	0.000832	CcSEcCtD
Dihydroxyaluminium—Vomiting—Clonazepam—epilepsy syndrome	0.00011	0.000825	CcSEcCtD
Dihydroxyaluminium—Vomiting—Phenytoin—epilepsy syndrome	0.000109	0.00082	CcSEcCtD
Dihydroxyaluminium—Nausea—Felbamate—epilepsy syndrome	0.000109	0.000817	CcSEcCtD
Dihydroxyaluminium—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000109	0.000815	CcSEcCtD
Dihydroxyaluminium—Dizziness—Carbamazepine—epilepsy syndrome	0.000109	0.000814	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000109	0.000814	CcSEcCtD
Dihydroxyaluminium—Pain—Valproic Acid—epilepsy syndrome	0.000108	0.000808	CcSEcCtD
Dihydroxyaluminium—Nausea—Zonisamide—epilepsy syndrome	0.000107	0.0008	CcSEcCtD
Dihydroxyaluminium—Hypotension—Pregabalin—epilepsy syndrome	0.000107	0.000798	CcSEcCtD
Dihydroxyaluminium—Dizziness—Lamotrigine—epilepsy syndrome	0.000105	0.000786	CcSEcCtD
Dihydroxyaluminium—Oedema—Gabapentin—epilepsy syndrome	0.000105	0.000783	CcSEcCtD
Dihydroxyaluminium—Vomiting—Carbamazepine—epilepsy syndrome	0.000104	0.000782	CcSEcCtD
Dihydroxyaluminium—Back pain—Topiramate—epilepsy syndrome	0.000104	0.000781	CcSEcCtD
Dihydroxyaluminium—Infection—Gabapentin—epilepsy syndrome	0.000104	0.000778	CcSEcCtD
Dihydroxyaluminium—Nausea—Clonazepam—epilepsy syndrome	0.000103	0.000771	CcSEcCtD
Dihydroxyaluminium—Nausea—Phenytoin—epilepsy syndrome	0.000102	0.000766	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Gabapentin—epilepsy syndrome	0.000102	0.000765	CcSEcCtD
Dihydroxyaluminium—Nausea—Oxcarbazepine—epilepsy syndrome	0.000102	0.000762	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Topiramate—epilepsy syndrome	0.000102	0.000761	CcSEcCtD
Dihydroxyaluminium—Vomiting—Lamotrigine—epilepsy syndrome	0.000101	0.000756	CcSEcCtD
Dihydroxyaluminium—Urticaria—Valproic Acid—epilepsy syndrome	0.0001	0.000751	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Valproic Acid—epilepsy syndrome	9.97e-05	0.000747	CcSEcCtD
Dihydroxyaluminium—Hypotension—Gabapentin—epilepsy syndrome	9.77e-05	0.000732	CcSEcCtD
Dihydroxyaluminium—Nausea—Carbamazepine—epilepsy syndrome	9.75e-05	0.000731	CcSEcCtD
Dihydroxyaluminium—Pain—Pregabalin—epilepsy syndrome	9.75e-05	0.000731	CcSEcCtD
Dihydroxyaluminium—Vertigo—Topiramate—epilepsy syndrome	9.68e-05	0.000726	CcSEcCtD
Dihydroxyaluminium—Nausea—Lamotrigine—epilepsy syndrome	9.43e-05	0.000706	CcSEcCtD
Dihydroxyaluminium—Convulsion—Topiramate—epilepsy syndrome	9.34e-05	0.0007	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Valproic Acid—epilepsy syndrome	9.29e-05	0.000696	CcSEcCtD
Dihydroxyaluminium—Urticaria—Pregabalin—epilepsy syndrome	9.06e-05	0.000679	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Pregabalin—epilepsy syndrome	9.01e-05	0.000675	CcSEcCtD
Dihydroxyaluminium—Pain—Gabapentin—epilepsy syndrome	8.94e-05	0.00067	CcSEcCtD
Dihydroxyaluminium—Oedema—Topiramate—epilepsy syndrome	8.8e-05	0.000659	CcSEcCtD
Dihydroxyaluminium—Infection—Topiramate—epilepsy syndrome	8.74e-05	0.000655	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Valproic Acid—epilepsy syndrome	8.63e-05	0.000647	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Topiramate—epilepsy syndrome	8.58e-05	0.000643	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Pregabalin—epilepsy syndrome	8.4e-05	0.000629	CcSEcCtD
Dihydroxyaluminium—Dizziness—Valproic Acid—epilepsy syndrome	8.34e-05	0.000625	CcSEcCtD
Dihydroxyaluminium—Urticaria—Gabapentin—epilepsy syndrome	8.3e-05	0.000622	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Gabapentin—epilepsy syndrome	8.26e-05	0.000619	CcSEcCtD
Dihydroxyaluminium—Hypotension—Topiramate—epilepsy syndrome	8.22e-05	0.000616	CcSEcCtD
Dihydroxyaluminium—Vomiting—Valproic Acid—epilepsy syndrome	8.02e-05	0.000601	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Pregabalin—epilepsy syndrome	7.8e-05	0.000585	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Gabapentin—epilepsy syndrome	7.7e-05	0.000577	CcSEcCtD
Dihydroxyaluminium—Dizziness—Pregabalin—epilepsy syndrome	7.54e-05	0.000565	CcSEcCtD
Dihydroxyaluminium—Pain—Topiramate—epilepsy syndrome	7.52e-05	0.000564	CcSEcCtD
Dihydroxyaluminium—Nausea—Valproic Acid—epilepsy syndrome	7.49e-05	0.000561	CcSEcCtD
Dihydroxyaluminium—Vomiting—Pregabalin—epilepsy syndrome	7.25e-05	0.000543	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Gabapentin—epilepsy syndrome	7.15e-05	0.000536	CcSEcCtD
Dihydroxyaluminium—Urticaria—Topiramate—epilepsy syndrome	6.99e-05	0.000524	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Topiramate—epilepsy syndrome	6.95e-05	0.000521	CcSEcCtD
Dihydroxyaluminium—Dizziness—Gabapentin—epilepsy syndrome	6.91e-05	0.000518	CcSEcCtD
Dihydroxyaluminium—Nausea—Pregabalin—epilepsy syndrome	6.77e-05	0.000507	CcSEcCtD
Dihydroxyaluminium—Vomiting—Gabapentin—epilepsy syndrome	6.65e-05	0.000498	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Topiramate—epilepsy syndrome	6.48e-05	0.000486	CcSEcCtD
Dihydroxyaluminium—Nausea—Gabapentin—epilepsy syndrome	6.21e-05	0.000465	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Topiramate—epilepsy syndrome	6.02e-05	0.000451	CcSEcCtD
Dihydroxyaluminium—Dizziness—Topiramate—epilepsy syndrome	5.82e-05	0.000436	CcSEcCtD
Dihydroxyaluminium—Vomiting—Topiramate—epilepsy syndrome	5.59e-05	0.000419	CcSEcCtD
Dihydroxyaluminium—Nausea—Topiramate—epilepsy syndrome	5.22e-05	0.000392	CcSEcCtD
